Journal of Cancer Clinical Trials

Department of Clinical Research, University of Alexandria, Alexandria Governorate, Egypt

Publications

• Mini Review   
  An Overview of Immune Checkpoint Inhibitors in the Treatment of Gynecological Cancer
  Author(s): Youssef El-Sayed*
  
  Immune Checkpoint Inhibitors (ICIs) have emerged as a groundbreaking therapeutic modality in the field of oncology, offering new hope for patients with various types of cancer, including gynecological malignancies. These inhibitors target immune checkpoints, key regulators of the immune system, to enhance the body's antitumor response. This article provides an extensive overview of the role of ICIs in the treatment of gynecological cancers, including cervical, ovarian, and endometrial cancers. It discusses the mechanism of action, clinical efficacy, ongoing research, and future prospects of these therapies. The literature review highlights key clinical trials and studies that have shaped the current understanding of ICIs in gynecological oncology. Furthermore, the discussion section addresses the challenges, limitations, and potential strategies to overcome .. Read More»
  DOI: 10.37421/2577-0535.2024.9.254

  Abstract HTML PDF